# Generex Biotechnology

Generex Biotechnology is an other based in Toronto, Canada.

## Overview

- **Organization type:** other
- **Headquarters:** Toronto, Canada
- **Region:** North America
- **Address:** Toronto, ON, Canada
- **Assets under management:** Undisclosed
- **Website:** generex.com

## Regulatory record

- **Reports private funds:** No

## About

Generex Biotechnology is a healthcare holding company based in Miramar, Florida. It focuses on patient-centric care across immune-oncology, medical devices, and diagnostics. The company offers end-to-end solutions through a management services organization and a network of pharmacies, a clinical laboratory, and medical device companies.

## Sectors

- Biotech
- Pharmaceuticals

## Questions

### Who controls Generex Biotechnology?

Generex Biotechnology is a publicly traded company (OTC: GNBT), meaning its governance is through a board of directors rather than a single controlling entity. No named individuals or family offices have been publicly disclosed as principal owners or managers (per public SEC filings).

### What is Generex's primary product and development status?

Generex's most recognized product is Oral-lyn, an oral insulin spray for diabetes management. As of public sources, the product has not received FDA approval and its clinical trial results have been reported but not sufficient for commercialization (per the firm's own communications).

### Does Generex have partnerships or external investors?

Public records do not identify any institutional allocators, family offices, or major strategic partners with disclosed commitments. The company has historically raised funds through public equity offerings and at-the-market offerings (per SEC filings).

## Related profiles

- [Tokyo Ohka Kogyo](https://altss.com/profile/tokyo-ohka-kogyo)
- [Qognify Ltd.](https://altss.com/profile/qognify-ltd)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/generex-biotechnology

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology